High glucose (HG), a hallmark of the tumour microenvironment, is also a biomechanical stressor, as it exerts hyper-osmotic stress (HG-HO), but not much is known regarding how tumour cells mechanoadapt to HG-HO. Therefore, this study aimed to delineate the novel molecular mechanisms by which tumour cells mechanoadapt to HG/HG-HO and whether phytochemical-based interference in these mechanisms can generate tumour-cell-selective vulnerability to cell death. Mannitol and L-glucose were used as hyper-osmotic equivalents of high glucose. The results revealed that the tumour cells can efficiently mechanoadapt to HG-HO only in the normoxic microenvironment. Under normoxic HG/HG-HO stress, tumour cells polySUMOylate a higher pool of mitotic driver pH3(Ser10), which translocates to the nucleus and promotes faster cell divisions. On the contrary, acute hypoxia dampens HG/HG-HO-associated excessive proliferation by upregulating sentrin protease SENP7. SENP7 promotes abnormal SUMOylation of pH3(Ser10), thereby restricting its nuclear entry and promoting the M-phase arrest and cell loss. However, the hypoxia-arrested cells that managed to survive showed relapse upon reversal to normoxia as well as upregulation of pro-survival-associated SENP1, and players in tumour growth signalling, autophagy, glycolytic pathways etc. Depletion of SENP1 in both normoxia and hypoxia caused significant loss of tumour cells vs undepleted controls. SENP1 was ascertained to restrict the abnormal SUMOylation of pH3(Ser10) in both normoxia and hypoxia, although not so efficiently in hypoxia, due to the opposing activity of SENP7. Co-treatment with Momordin Ic (MC), a natural SENP1 inhibitor, and Gallic Acid (GA), an inhibitor of identified major pro-tumourigenic signalling (both enriched in Momordica charantia), eliminated surviving tumour cells in normal glucose, HG and HG-HO normoxic and hypoxic microenvironments, suggesting that appropriate and enhanced polySUMOylation of pH3(Ser10) in response to HG/HG-HO stress was attenuated by this treatment along with further dampening of other key tumourigenic signalling, due to which tumour cells could no longer proliferate and grow.
Natural polyphenol-rich interventions are widely investigated for antioxidant protection, yet whether such interventions influence non-redox mechanisms of cardiac mechanoadaptation remains incompletely understood. Amalaki Rasayana (AR) is a traditional phytomedicine with antioxidant properties used for cardioprotection. Here, we investigated whether extracellular C-terminal-epitope-reactive Galectin-3 (Gal-3) species are associated with altered cardiomyocyte surface organization and mechanotransduction-associated signaling, and whether these responses are modulated by AR. In complementary mechanistic cardiomyocyte cell-culture experiments, we further examined whether gallic acid (GA), an analytically prominent and bioavailable constituent of AR, recapitulates selected AR-associated anti-hypertrophic effects. Using biologically aged and left ventricular pressure-overload rat models, followed by complementary in vitro cardiomyocyte mechanical-loading assays, biochemical and imaging approaches, and exploratory analyses of human serum and myocardial tissue, we examined epitope-resolved Gal-3 species, their compartmental distribution and surface-associated clustering, and associated mechanotransduction responses. Pressure overload increased extracellular and surface-associated C-terminal-epitope-reactive Gal-3 species, including a higher-molecular-weight population distinct from full-length Gal-3, accompanied by reduced intracellular Gal-3 and hypertrophic remodeling. C-terminal-epitope-enriched human serum induced surface-associated Gal-3 clustering and altered calcium responses, RhoA–ROCK1-F-actin organization, the NFATC2–MEF2A hypertrophic transcriptional axis, and nuclear stress responses. AR attenuated hypertrophic remodeling while shifting Gal-3 distribution away from extracellular and surface-associated C-terminal-epitope-reactive species toward intracellular retention. In complementary mechanical-loading experiments, GA recapitulated selected AR-associated effects. Additional mechanistic experiments supported roles for Gal-3 C-terminal-epitope (carbohydrate-recognition domain, CRD)-dependent surface engagement and Ser6-phosphorylation-sensitive regulation of intracellular Gal-3. Together, these findings support a potentially non-canonical, Gal-3-centered mechanism through which a polyphenol-rich antioxidant intervention may modulate pathological cardiac mechanoadaptation by regulating Gal-3 compartmentalization and surface engagement.